PROM1 and neoplasm: As expected, we observed a significantly smaller mean CD133-positive tumor cell area for the VS-6063−treated group relative to the vehicle group (2.1 vs. 46.6 μm2/cell, respectively; P < 0.05) (Fig 6C).